Literature DB >> 19079650

Putative precursor cancer cells in human colorectal cancer tissue.

Teodora E Goranova1, Masayuki Ohue, Kikuya Kato.   

Abstract

Multistage carcinogenesis is an important concept in cancer biology. Each new stage is triggered by the acquisition of an additional genetic aberration, leading to clonal expansion of the cancer cell. The resulting tumor mass consists of cancer cells with all genetic aberrations, but may include precursor cells at some point of carcinogenesis. We analyzed six colorectal cancer tissues with APC, K-ras, and p53 mutations. From each sample, 40-50 areas (100x100x40microm) consisting only of cancer cells were microdissected, and genomic DNA was purified. Ratios of mutated and normal alleles were quantitated by the SNaPshot assay, a primer extension assay. In five tumor tissues, we identified cancer cell subpopulations corresponding to putative precursors, i.e., cells with mutations in one or two of the three genes. All samples were likely to be of monoclonal origin, and temporal sequences of the mutations could be deduced from the mutation patterns of putative precursors. The orders of mutation events were variable. However, the two carcinoma tissues accompanying adenoma regions started with the APC mutation, not contradicting the previous studies. The analysis also revealed considerable heterogeneity in allele ratios of one or two of the chromosomes. The current findings are promising to uncover the process of carcinogenesis directly from the tumor tissue of the patient.

Entities:  

Keywords:  cancer stem cell; carcinogenesis; chromosome copy number variation; intratumor heterogeneity; somatic mutation

Year:  2008        PMID: 19079650      PMCID: PMC2584340     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Laser microdissection and microsatellite analyses of breast cancer reveal a high degree of tumor heterogeneity.

Authors:  P Wild; R Knuechel; W Dietmaier; F Hofstaedter; A Hartmann
Journal:  Pathobiology       Date:  2000       Impact factor: 4.342

2.  Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.

Authors:  B Baisse; H Bouzourene; E P Saraga; F T Bosman; J Benhattar
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

3.  Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.

Authors:  Y Takeshima; V J Amatya; Y Daimaru; F Nakayori; T Nakano; K Inai
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

4.  Top-down morphogenesis of colorectal tumors.

Authors:  I M Shih; T L Wang; G Traverso; K Romans; S R Hamilton; S Ben-Sasson; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

5.  Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity.

Authors:  R Barnetson; J Jass; R Tse; R Eckstein; B Robinson; M Schnitzler
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

6.  X-inactivation patch size in human female tissue confounds the assessment of tumor clonality.

Authors:  Marco Novelli; Antonio Cossu; Dahmane Oukrif; Alberto Quaglia; Sunil Lakhani; Richard Poulsom; Peter Sasieni; Piera Carta; Marcella Contini; Anna Pasca; Giuseppe Palmieri; Walter Bodmer; Francesco Tanda; Nick Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-27       Impact factor: 11.205

7.  Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.

Authors:  Heidi Lyng; Marzieh Beigi; Debbie H Svendsrud; Odd T Brustugun; Trond Stokke; Gunnar B Kristensen; Kolbein Sundfør; Ane Skjønsberg; Paula M De Angelis
Journal:  Int J Cancer       Date:  2004-09-01       Impact factor: 7.396

8.  Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib.

Authors:  Kazuya Taniguchi; Jiro Okami; Ken Kodama; Masahiko Higashiyama; Kikuya Kato
Journal:  Cancer Sci       Date:  2008-03-04       Impact factor: 6.716

9.  Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage.

Authors:  Joshua M Uronis; Hans H Herfarth; Tara C Rubinas; Anika C Bissahoyo; Kathleen Hanlon; David W Threadgill
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

10.  Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer.

Authors:  W Giaretti; A Rapallo; A Sciutto; B Macciocu; E Geido; M A Hermsen; C Postma; J P Baak; R A Williams; G A Meijer
Journal:  Anal Cell Pathol       Date:  2000       Impact factor: 2.916

View more
  5 in total

1.  SNaPshot Assay in Quantitative Detection of Allelic Nondisjunction in Down Syndrome.

Authors:  Debarati Ghosh; Sailesh Gochhait; Disha Banerjee; Anindita Chatterjee; Swagata Sinha; Krishnadas Nandagopal
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-29

2.  Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas.

Authors:  Anna De Grassi; Fabio Iannelli; Matteo Cereda; Sara Volorio; Valentina Melocchi; Alessandra Viel; Gianluca Basso; Luigi Laghi; Michele Caselle; Francesca D Ciccarelli
Journal:  Genome Biol       Date:  2014-08-30       Impact factor: 13.583

3.  Limited importance of the dominant-negative effect of TP53 missense mutations.

Authors:  Ewelina Stoczynska-Fidelus; Malgorzata Szybka; Sylwester Piaskowski; Michal Bienkowski; Krystyna Hulas-Bigoszewska; Mateusz Banaszczyk; Izabela Zawlik; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Pawel P Liberski; Piotr Rieske
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

4.  Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors.

Authors:  Teodora Evgenieva Goranova; Masayuki Ohue; Yutaro Shimoharu; Kikuya Kato
Journal:  Clin Exp Metastasis       Date:  2011-03-05       Impact factor: 5.150

5.  cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer.

Authors:  Malgorzata Szybka; Magdalena Zakrzewska; Piotr Rieske; Grazyna Pasz-Walczak; Dominika Kulczycka-Wojdala; Izabela Zawlik; Robert Stawski; Dorota Jesionek-Kupnicka; Pawel P Liberski; Radzislaw Kordek
Journal:  BMC Cancer       Date:  2009-08-11       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.